Leadership: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
[[File:Yassmine Akkari.png|center|thumb|Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; '''Associate Editor CCGA [ALL Section]''']] | [[File:Yassmine Akkari.png|center|thumb|Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; '''Associate Editor CCGA [ALL Section]''']] | ||
[[File:Snehal Patel1.jpg|center|thumb|Snehal Patel, MD, PhD; '''Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Mature T- and NK-cell Neoplasms]''']] | [[File:Snehal Patel1.jpg|center|thumb|Snehal Patel, MD, PhD; '''Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]''']] | ||
[[File:Greg Corboy photo1.jpg|center|thumb|Greg Corboy, PhDLabPlus Auckland City Hospital (Auckland, New Zealand), School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); '''Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section]''']] | [[File:Greg Corboy photo1.jpg|center|thumb|Greg Corboy, PhDLabPlus Auckland City Hospital (Auckland, New Zealand), School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); '''Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section]''']] | ||